TXG — 10X Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for 10X Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	664	587	430	389	393
Net Total Accounts Receivable
Net Total Receivables	51.2	85.3	104	115	87.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	774	748	635	596	584
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	120	230	359	345	310
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	929	1,019	1,029	965	919
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	118	110	131	127	118
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	190	201	223	224	209
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	739	818	806	741	710
Total Liabilities & Shareholders' Equity	929	1,019	1,029	965	919
Total Common Shares Outstanding